N-(2,6-DICHLORO-2'-(TRIFLUOROMETHOXY)-[1,1'-BIPHENYL]-4-YL)-2-(4-(ETHYLSULFONYL)PHENYL)ACETAMIDE, 95%, 25mg

(R)-2-Benzyl-2-N-Boc-amino-ethyl thiol, 97.0%, 1g

methyl 2-(6-butyl-2-iminobenzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 250mg

Tetradecanoic acid, 95.0%, 500g

2-Hydroxy-4-methoxy-benzaldehyde, 98.0%, 100g

(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate, 95.0%, 100g

anti-Keratin K19 mouse monoclonal, Ks19.2 (Z105.6), 1 ml

1-(2,4,6-Trihydroxyphenyl)ethanone, 98.0%, 25g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 5g

4-(3-(BROMOMETHYL)PHENYL)MORPHOLINE HYDROBROMIDE, 95.0%, 250mg

2,3-Difluorobenzyl Alcohol>98.0%(GC)25g

BIS-N,N'-BOC-L-LYSINE METHYL ESTER, 95.0%, 5g

1-Benzyloxy-3-iodobenzene>97.0%(GC)5g